Compare KURA & TYG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | KURA | TYG |
|---|---|---|
| Founded | 2014 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 860.2M |
| IPO Year | N/A | N/A |
| Metric | KURA | TYG |
|---|---|---|
| Price | $10.36 | $40.89 |
| Analyst Decision | Buy | |
| Analyst Count | 11 | 0 |
| Target Price | ★ $25.00 | N/A |
| AVG Volume (30 Days) | ★ 1.7M | 128.8K |
| Earning Date | 11-04-2025 | 02-06-2026 |
| Dividend Yield | N/A | ★ 10.71% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 5.19 |
| Revenue | ★ $104,029,000.00 | $18,090,640.00 |
| Revenue This Year | $138.16 | N/A |
| Revenue Next Year | $66.98 | N/A |
| P/E Ratio | ★ N/A | $7.89 |
| Revenue Growth | N/A | ★ 32.84 |
| 52 Week Low | $5.41 | $33.73 |
| 52 Week High | $12.49 | $48.76 |
| Indicator | KURA | TYG |
|---|---|---|
| Relative Strength Index (RSI) | 46.43 | 38.01 |
| Support Level | $9.68 | $40.35 |
| Resistance Level | $11.28 | $42.02 |
| Average True Range (ATR) | 0.49 | 0.55 |
| MACD | -0.05 | -0.06 |
| Stochastic Oscillator | 42.50 | 26.89 |
Kura Oncology Inc is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The company's pipeline consists of small molecule drug candidates targeting cancer signaling pathways.
Tortoise Energy Infrastructure Corp seeks to provide a high level of current income to stockholders. It invests in fixed-income and dividend-paying equity securities of power and energy infrastructure companies that provide stable and defensive characteristics throughout economic cycles.